CONTACT ME


  • Kimberly A. Kralowec
    Schubert Jonckheer Kolbe & Kralowec LLP
    Three Embarcadero Center,
    Suite 1650
    San Francisco, CA 94111
    Telephone: (415) 788-4220
    Facsimile: (415) 788-0161
    Email: uclpractitioner@gmail.com

July 2009

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Disclaimer


  • Nothing in this blog constitutes legal advice. If you need legal advice, consult an attorney in your jurisdiction. To read this blog's complete disclaimer, click here.


  • The UCL Practitioner
    © 2003-2009
    by Kimberly A. Kralowec
    All rights reserved.


  • Enter your email address:

    Delivered by FeedBurner




  • Header design by Webmotion
    Photos by Jack Gescheidt
    Powered by TypePad

« Registration now open for CAOC's Third Annual Class Action Seminar | Main | New class member discovery decision: Crab Addison, Inc. v. Superior Court »

Wednesday, December 24, 2008

Ninth Circuit denies en banc rehearing and modifies its opinion in Williams v. Gerber Products Co.

On Monday, the Ninth Circuit issued an order denying en banc rehearing and modifying its opinion in Williams v. Gerber Products Co., 523 F.3d 934 (9th Cir. 2008). Originally, the opinion contained these three sentences:

We do not, however, think that a busy parent walking through the aisles of a grocery store should be expected to verify that the representations on the front of the box are confirmed in the ingredient list. Instead, reasonable consumers expect that the ingredient list contains more detailed information about the product that confirms other representations on the packaging. We do not think that the FDA requires an ingredient list so that manufacturers can mislead consumers and then rely on the ingredient list to correct those misinterpretations and provide a shield for liability for the deception.

Slip op. at 4197 (emphasis added). The first sentence has been omitted, and the other two reversed, to read:

We do not think that the FDA requires an ingredient list so that manufacturers can mislead consumers and then rely on the ingredient list to correct those misinterpretations and provide a shield for liability for the deception. Instead, reasonable consumers expect that the ingredient list contains more detailed information about the product that confirms other representations on the packaging.

Slip op. at 16639.  Here is my original blog post on the Gerber decision.  Thanks to the blog reader who emailed to advise of this development.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8345172b069e20105368ef4e8970b

Listed below are links to weblogs that reference Ninth Circuit denies en banc rehearing and modifies its opinion in Williams v. Gerber Products Co. :

Comments

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Research


California Law Blogs